Clinical trial · Observational
Changes in Body Composition With Patients Under Androgen Deprivation Therapy
Body Compositions Change in Patients With Prostate Cancer Treated With Androgen Deprivation Therapy
NCT04037488CI-TRIAL-00039804unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aimed to evaluate the correlation of change in body composition and oncological outcomes of prostate cancer patients under androgen deprivation therapy(ADT).
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
| Sarcopenia | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Inbody 320 | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Cohort: ADT patients
- description
- All enrolled patient data entered in single group cohort. All patient who started androgen deprivation therapy for prostate cancer can included this cohort by following inclusion and exclusion criteria. We do not planned any intervention on this cohort. We measuring changes of body composition by Inbody 320 in the planned follow-up period. We planned sub-group analysis for timing of intervention (Intervention 1) , ADT type(Intervention 2), LHRH agonist type(Intervention 3), patients age(Intervention 4), initial PSA level (Intervention 5) and Gleason Grade Group (Intervention 6).
- interventionNames
- Diagnostic Test: Inbody 320
Primary outcomes (4)
- measure
- Body composition change-Skeletal muscle index (SMI)
- timeFrame
- Baseline (preADT) and Post ADT 3, 6, 12, 18, 24 months
- description
- Lean body mas (kg) / body weight (kg) x 100 (%)
- measure
- Body composition change-Body mass index (BMI)
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: * Age over 20 year-old * Patient with ECOG-PS 0 to 2 * Prostate cancer patients * Considered Androgen deprivation therapy with any cause * Patient agreed with informed consent of this study Exclusion Criteria: * History of previous ADT * Planned intermittent treatment or short term ADT (less than 2 year) * Contraindication of ADT * Severe cognitive impairment, who cannot eligible for survey * Secondary malignancy * Patient cannot perform InBody test because of physical or underlying disease.
References
Publications (0)
Data not yet available
No reference posted for this study.